Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Discover the best timing for robo versus manual investing in 2026. This intro outlines criteria, costs, and expected outcomes to guide your choice.
26,911 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Ethereum is forming a potential base after a sharp February selloff, with key support holding around $1,800-$1,700. A...
Washington eyes a softer Basel III endgame, freeing up about $175B in excess bank capital. Crypto markets are watchin...
Oil climbs above $95 as equities pause, with the S&P 500 near unchanged. Delta raises its Q1 revenue outlook, while t...
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...
Major League Baseball announces a formal partnership with Polymarket and an integrity pact with the CFTC to guide pre...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
As SpaceX moves closer to a historic IPO, investors are eyeing space peers for immediate upside. This report highligh...
Oil climbs toward the $100-per-barrel level as the Iran conflict enters its fourth week. Traders warn that volatility...
Bitcoin slid in early trading as a macro selloff collided with Deribit’s huge BTC options expiry, pushing BTC toward ...
GameStop disclosed a non-binding $55.5 billion bid to buy eBay at $125 per share, financed with cash and leverage. Th...
Central Valley peach growers confront a costly and abrupt pivot after Del Monte closures. About 3,000 acres will be u...